Skip to main content
ACS AuthorChoice logoLink to ACS AuthorChoice
. 2016 May 20;10(6):6416. doi: 10.1021/acsnano.6b03110

Correction to Use of a Lipid-Coated Mesoporous Silica Nanoparticle Platform for Synergistic Gemcitabine and Paclitaxel Delivery to Human Pancreatic Cancer in Mice

Huan Meng , Meiying Wang, Huiyu Liu, Xiangsheng Liu, Allen Situ, Bobby Wu, Zhaoxia Ji, Chong Hyun Chang, Andre E Nel
PMCID: PMC4928141  PMID: 27199284

Page 3555. In the Acknowledgment, the original statement reads “This study was funded by the U.S. Public Health Service Grant RO1 CA133697. H.L. was partially supported by the National Natural Science Foundation of China No. 31271075.” It should be replaced with “This study was funded by the U.S. Public Health Service Grants RO1 CA133697 and U01 CA198846. H.L. was partially supported by the National Natural Science Foundation of China No. 31271075.”

The update on the acknowledgment does not affect any of the experimental results, discussions, or conclusions reported in the paper.


Articles from ACS Nano are provided here courtesy of American Chemical Society

RESOURCES